EUVIMEDEUVIMED entdecken
Crossref

DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma

Ying Cao, Ruolan Qian, Ruilian Yao, Quan Zheng, Chen Yang, Xupeng Yang, Shuyi Ji, Linmen Zhang, Shujie Zhan, Yiping Wang, Tianshi Wang, Hui Wang und 7 weitere

Developmental Cell · 2025-05 · 60 (10) · 1483-1497.e7

DOI: 10.1016/j.devcel.2024.12.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developmental Cell, 2025-05. Verfasst von Ying Cao und 18 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Sha…. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Liver Neoplasms, Carcinoma, Hepatocellular, Protein-Tyrosine Kinases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, Shanghai Jiao Tong University, School of Medicine, Shanghai Jiao Tong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesLiver NeoplasmsCarcinoma, HepatocellularProtein-Tyrosine KinasesTransforming Growth Factor betaOxidative PhosphorylationDyrk KinasesHumansAnimalsSignal TransductionMiceMitochondriaCell Line, TumorXenograft Model Antitumor AssaysPhosphorylationPyrazolesQuinolines

Stichwörter der Autor:innen

DYRK1AIACS-010759TGF-β signalinghepatocellular carcinomaoxidative phosphorylation

Substanzen

Dyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesTransforming Growth Factor betaLY-2157299PyrazolesQuinolines

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
  • Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Liver Surgery and Transplantation, Key Laboratory of Carcinogenesis and Cancer Invasion, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Precision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Nephrology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • Shanghai Jiao Tong University
  • School of Medicine, Shanghai Jiao Tong University
  • National Key Research and Development Program of China
  • Shanghai Municipal Education Commission
  • Shanghai Key Basic Research Program
  • Xi'an Eurasia University
  • National Natural Science Foundation of China

Zitieren

APA

Cao, Y., Qian, R., Yao, R., Zheng, Q., Yang, C., Yang, X., Ji, S., Zhang, L., Zhan, S., Wang, Y., Wang, T., Wang, H., Wong, C. M., Yuan, S., Heeschen, C., Gao, Q., Bernards, R., Qin, W., & Wang, C. (2025). DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma. Developmental Cell, 60(10), 1483-1497.e7. https://doi.org/10.1016/j.devcel.2024.12.035

Vancouver

Cao Y, Qian R, Yao R, Zheng Q, Yang C, Yang X, et al. DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma. Developmental Cell. 2025;60(10):1483-1497.e7. doi:10.1016/j.devcel.2024.12.035

BibTeX
@article{Cao2025,
  author = {Cao, Ying and Qian, Ruolan and Yao, Ruilian and Zheng, Quan and Yang, Chen and Yang, Xupeng and Ji, Shuyi and Zhang, Linmen and Zhan, Shujie and Wang, Yiping and Wang, Tianshi and Wang, Hui and Wong, Chun-Ming and Yuan, Shengxian and Heeschen, Christopher and Gao, Qiang and Bernards, René and Qin, Wenxin and Wang, Cun},
  title = {DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma},
  journal = {Developmental Cell},
  year = {2025},
  volume = {60},
  number = {10},
  pages = {1483--1497.e7},
  doi = {10.1016/j.devcel.2024.12.035}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche